Anti-inflammatory diet and physical therapy for children with psoriasis
Part of Skin clinical trials.
This trial tests if adding a gluten-free, low-histamine anti-inflammatory diet, and in some cases physical therapy, helps children with mild-to-moderate plaque psoriasis. It aims to see if these lifestyle changes can improve skin symptoms when combined with usual treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with plaque psoriasis by a skin doctor for at least 6 months
- Age between 6 and 17 years old
- Mild to moderate psoriasis (score of 20 or less on a special skin severity scale called P-PASI)
- Stable psoriasis treatment for at least 8 weeks before starting the study
- Able to follow a gluten-free, low-histamine anti-inflammatory diet, and possibly a physical therapy program
- Parent or guardian must give permission, and children age 8-17 must agree to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a dietary approach can help people with mild-to-moderate psoriasis. It may be especially focused on people who do not have signs of wheat/gluten-related immune reactions.
This trial tests how safe and how the body handles (pharmacokinetics) a psoriasis lotion called IDP-122 when used in children with plaque psoriasis. You may be able to join if your child has a suitable amount of plaque psoriasis and can follow safety rules during the study.
This study tests whether adding a Mediterranean diet to your psoriasis treatment can improve your skin. You will be asked to follow a heart-healthy diet for several months while taking a new biologic medicine.
This study uses a full-body PET scan to see if switching to a balanced, nutritious diet can lower inflammation throughout the body and in the skin for people with psoriasis. It may help if you are overweight and have a poor diet.
This trial studies how guselkumab works for people with long-lasting, more severe psoriasis and signs that may affect joints. It may help by improving psoriasis symptoms and possibly reducing related inflammation, while researchers track safety and outcomes.
This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.